Microarray Analysis of Human Blood During Electroconvulsive Therapy
Open Access
- 1 December 2015
- journal article
- research article
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 31 (4) , 234-237
Abstract
Introduction Electroconvulsive therapy (ECT) is currently regarded as a significant treatment option for intractable psychiatric disorders, such as catatonic schizophrenia or treatment-resistant depression; however, the underlying molecular mechanism for its therapeutic effect remains obscure. Methods Employing microarray analysis (Human Genome U133 Plus 2.0 Array; Affymetrix, United States) of cDNA derived from the peripheral blood of patients with catatonic schizophrenia (n = 5), we detected a significant change in 145 genes (0.68%) before and after modified ECT (mECT). Moreover, we performed quantitative polymerase chain reaction validation of genes that had previously been suggested to be functionally related to schizophrenia. Results Of 4 genes examined (AKT3, TCF7, PPP3R1, and GADD45B), only TCF7 was increased during the mECT procedure (P = 0.0025). Discussion This study describes the first attempt to uncover the molecular mechanism of mECT using a microarray assay of mRNA derived from peripheral blood, and our results suggest that the TCF family may play a role in the functional mechanism of mECT.Keywords
This publication has 30 references indexed in Scilit:
- Indications for electroconvulsive treatment in schizophrenia: A systematic reviewSchizophrenia Research, 2013
- ECT in Treatment-Resistant DepressionAmerican Journal of Psychiatry, 2012
- Using ECT in schizophrenia: A review from a clinical perspectiveThe World Journal of Biological Psychiatry, 2011
- How Does Electroconvulsive Therapy Work? Theories on its MechanismThe Canadian Journal of Psychiatry, 2011
- Changes in neuropeptide Y gene expression in the spinal cord of chronic constrictive injury model rats after electroconvulsive stimulationBiomedical Research, 2010
- Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: Experimental evidence for involvement of COX-2, and review of literatureJournal of Psychiatric Research, 2008
- Electroconvulsive Therapy for DepressionNew England Journal of Medicine, 2007
- Src kinases: a hub for NMDA receptor regulationNature Reviews Neuroscience, 2004
- Genetic Approaches to the Neurobiology of Electroconvulsive TherapyThe Journal of ECT, 1998
- Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampusMolecular Brain Research, 1996